Synapse

← Nigel Mackman

Papers by Nigel Mackman

Page 1 · newest first

  1. Lack of canonical PAR4 activation is associated with reduced arterial and venous thrombosis in mice2026
  2. In a nutshell: Explaining joint and muscle bleeding in individuals with haemophilia A and BBritish Journal of Haematology · 2026
  3. Carbon tetrachloride (CCl4)-induced liver injury activates hepatocyte-independent tissue factor-driven coagulationJournal of Thrombosis and Haemostasis · 2026
  4. Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced MyocarditisJournal of the American College of Cardiology · 2013
  5. Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemiaResearch and Practice in Thrombosis and Haemostasis · 2025
  6. Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever VirusesArteriosclerosis Thrombosis and Vascular Biology · 2025
  7. Association between clonal mutations in Acute Myeloid Leukemia and novel fibrinolytic biomarkersBlood · 2025
  8. Profibrinolytic Factors and Cancer Progression, Metastasis, and SurvivalArteriosclerosis Thrombosis and Vascular Biology · 2025
  9. Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysisNature Communications · 2025
  10. Evaluation of a new commercial assay for the measurement of tissue factor activity of extracellular vesicles isolated from human plasmaResearch and Practice in Thrombosis and Haemostasis · 2025
  11. Optimization of a Western blot protocol for the detection of low levels of tissue factor in human cellsResearch and Practice in Thrombosis and Haemostasis · 2025
  12. Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malariaPLoS Pathogens · 2025
  13. Prothrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure StudySHILAP Revista de lepidopterología · 2025
  14. The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgeryBlood Advances · 2025
  15. Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis—Brief ReportArteriosclerosis Thrombosis and Vascular Biology · 2025
  16. Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infectionNature Communications · 2025
  17. Extravascular coagulation regulates haemostasis independently of activated platelet surfaces in an in vivo mouse modelCommunications Biology · 2025
  18. TGF-β Receptor–dependent Tissue Factor Release and Proteomic Profiling of Extracellular Vesicles from Mechanically Compressed Human Bronchial Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology · 2025
  19. Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertensionJHLT Open · 2024
  20. Platelets are Protective in Early Abdominal Aortic Aneurysm Formation2024
  21. Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE-/-vs. Ldlr-/-Mice2024
  22. Challenges with measuring tissue factor antigen and activity in human plasmaBlood Vessels Thrombosis & Hemostasis · 2024
  23. Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer SymptomsInflammation · 2024
  24. Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic targetBlood · 2024
  25. 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis modelBlood · 2024
  26. Abstract 155: Plasma Kallikrein Is A Key Driver Of Basal Activation Of Coagulation Under Conditions Of C1 Inhibitor DeficiencyArteriosclerosis Thrombosis and Vascular Biology · 2024
  27. Plasma kallikrein supports FXII-independent thrombin generation in mouse whole bloodBlood Advances · 2024
  28. Commentary: Macrophage IL-1β-positive microvesicles exhibit thrombo-inflammatory properties and are detectable in patients with active juvenile idiopathic arthritisFrontiers in Immunology · 2024
  29. Tissue Factor and COVID-19 Associated ThrombosisArteriosclerosis Thrombosis and Vascular Biology · 2024
  30. Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexesProceedings of the National Academy of Sciences · 2024
  31. Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection2024
  32. Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factorResearch and Practice in Thrombosis and Haemostasis · 2024
  33. Commentary: Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisFrontiers in Immunology · 2023
  34. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia2023
  35. Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisBlood · 2023
  36. Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerHaematologica · 2023
  37. 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse model of hemostasis2023
  38. Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolismJournal of Thrombosis and Haemostasis · 2023
  39. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemiaBlood Advances · 2023
  40. Glycoprotein VI is Critical for the Detection and Progression of Abdominal Aortic Aneurysms2023
  41. Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of CoagulationThrombosis and Haemostasis · 2023
  42. Detection of tissue factor–positive extracellular vesicles using the ExoView R100 systemResearch and Practice in Thrombosis and Haemostasis · 2023
  43. Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewNeuro-Oncology · 2023
  44. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolismJournal of Thrombosis and Haemostasis · 2023
  45. Data from Tissue Factor–Activated Coagulation Cascade in the Tumor Microenvironment Is Critical for Tumor Progression and an Effective Target for Therapy2023
  46. Mechanisms of cancer-associated thrombosisResearch and Practice in Thrombosis and Haemostasis · 2023
  47. Tissue factor activity of small and large extracellular vesicles in different diseasesResearch and Practice in Thrombosis and Haemostasis · 2023
  48. Evaluation of four commercial ELISAs to measure tissue factor in human plasmaResearch and Practice in Thrombosis and Haemostasis · 2023
  49. Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic CancerThrombosis and Haemostasis · 2023
  50. C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosisBlood · 2023